These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 30101540)

  • 1. Addressing Cancer Chemotherapeutic Toxicity, Resistance, and Heterogeneity: Novel Theranostic Use of DNA-Encoded Small Molecule Libraries.
    Kolodny G; Li X; Balk S
    Bioessays; 2018 Oct; 40(10):e1800057. PubMed ID: 30101540
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IGF1 Receptor Targeted Theranostic Nanoparticles for Targeted and Image-Guided Therapy of Pancreatic Cancer.
    Zhou H; Qian W; Uckun FM; Wang L; Wang YA; Chen H; Kooby D; Yu Q; Lipowska M; Staley CA; Mao H; Yang L
    ACS Nano; 2015 Aug; 9(8):7976-91. PubMed ID: 26242412
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Small molecules as theranostic agents in cancer immunology.
    Li J; Van Valkenburgh J; Hong X; Conti PS; Zhang X; Chen K
    Theranostics; 2019; 9(25):7849-7871. PubMed ID: 31695804
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fluorescent chemical probes for accurate tumor diagnosis and targeting therapy.
    Gao M; Yu F; Lv C; Choo J; Chen L
    Chem Soc Rev; 2017 Apr; 46(8):2237-2271. PubMed ID: 28319221
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor Penetrating Theranostic Nanoparticles for Enhancement of Targeted and Image-guided Drug Delivery into Peritoneal Tumors following Intraperitoneal Delivery.
    Gao N; Bozeman EN; Qian W; Wang L; Chen H; Lipowska M; Staley CA; Wang YA; Mao H; Yang L
    Theranostics; 2017; 7(6):1689-1704. PubMed ID: 28529645
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enzyme-Instructed Self-assembly in Biological Milieu for Theranostics Purpose.
    Huang Z; Yao Q; Wei S; Chen J; Gao Y
    Curr Med Chem; 2019; 26(8):1351-1365. PubMed ID: 28933284
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor Targeting Strategies of Smart Fluorescent Nanoparticles and Their Applications in Cancer Diagnosis and Treatment.
    He J; Li C; Ding L; Huang Y; Yin X; Zhang J; Zhang J; Yao C; Liang M; Pirraco RP; Chen J; Lu Q; Baldridge R; Zhang Y; Wu M; Reis RL; Wang Y
    Adv Mater; 2019 Oct; 31(40):e1902409. PubMed ID: 31369176
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Engineering Persistent Luminescence Nanoparticles for Biological Applications: From Biosensing/Bioimaging to Theranostics.
    Sun SK; Wang HF; Yan XP
    Acc Chem Res; 2018 May; 51(5):1131-1143. PubMed ID: 29664602
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Brain metastasis: An insight into novel molecular targets for theranostic approaches.
    Santos L; Moreira JN; Abrunhosa A; Gomes C
    Crit Rev Oncol Hematol; 2024 Jun; 198():104377. PubMed ID: 38710296
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Real-time near-infrared bioimaging of a receptor-targeted cytotoxic dendritic theranostic agent.
    Wu J; Zhou Y; Li S; Qu D; Zhu WH; Tian H
    Biomaterials; 2017 Mar; 120():1-10. PubMed ID: 28011190
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cyanine based Nanoprobes for Cancer Theranostics.
    Bhattarai P; Dai Z
    Adv Healthc Mater; 2017 Jul; 6(14):. PubMed ID: 28558146
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Concise Biothiol-Activatable HPQ-NBD Conjugate as a Targeted Theranostic Probe for Tumor Cells.
    Zhang Y; Liu C; Sun W; Yu Z; Su M; Rong X; Wang X; Wang K; Li X; Zhu H; Yu M; Sheng W; Zhu B
    Anal Chem; 2022 May; 94(19):7140-7147. PubMed ID: 35522825
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Turn-on theranostic fluorescent nanoprobe by electrostatic self-assembly of carbon dots with doxorubicin for targeted cancer cell imaging, in vivo hyaluronidase analysis, and targeted drug delivery.
    Gao N; Yang W; Nie H; Gong Y; Jing J; Gao L; Zhang X
    Biosens Bioelectron; 2017 Oct; 96():300-307. PubMed ID: 28511113
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeted nanomedicine for cancer therapeutics: Towards precision medicine overcoming drug resistance.
    Bar-Zeev M; Livney YD; Assaraf YG
    Drug Resist Updat; 2017 Mar; 31():15-30. PubMed ID: 28867241
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor-targeting peptides and small molecules as anti-cancer agents to overcome drug resistance.
    Sarafraz-Yazdi E; Pincus MR; Michl J
    Curr Med Chem; 2014; 21(14):1618-30. PubMed ID: 23992333
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reconsidering azobenzene as a component of small-molecule hypoxia-mediated cancer drugs: A theranostic case study.
    Verwilst P; Han J; Lee J; Mun S; Kang HG; Kim JS
    Biomaterials; 2017 Jan; 115():104-114. PubMed ID: 27886551
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mitochondrial targeting theranostic nanomedicine and molecular biomarkers for efficient cancer diagnosis and therapy.
    Rout SK; Priya V; Setia A; Mehata AK; Mohan S; Albratty M; Najmi A; Meraya AM; Makeen HA; Tambuwala MM; Muthu MS
    Biomed Pharmacother; 2022 Sep; 153():113451. PubMed ID: 36076564
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oligonucleotide-based theranostic nanoparticles in cancer therapy.
    Shahbazi R; Ozpolat B; Ulubayram K
    Nanomedicine (Lond); 2016 May; 11(10):1287-308. PubMed ID: 27102380
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Advancements in Applications of Surface Modified Nanomaterials for Cancer Theranostics.
    Ahmad IZ; Kuddus M; Tabassum H; Ahmad A; Mabood A
    Curr Drug Metab; 2017; 18(11):983-999. PubMed ID: 28969548
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A dual-targeting DNA tetrahedron nanocarrier for breast cancer cell imaging and drug delivery.
    Liu X; Wu L; Wang L; Jiang W
    Talanta; 2018 Mar; 179():356-363. PubMed ID: 29310244
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.